Patents by Inventor Svetlana HAMM

Svetlana HAMM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210145799
    Abstract: The invention relates to pharmaceutical combination products comprising an HD AC inhibitor, e.g. (E)-N-(2-amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide as well as salts and or solvents thereof and TLR7 agonist and/or TLR8 agonist for the treatment of cancer. The present invention also relates to methods of treatment of patients suffering from cancer with these pharmaceutical combination products.
    Type: Application
    Filed: April 15, 2019
    Publication date: May 20, 2021
    Applicant: 4SC AG
    Inventor: Svetlana HAMM
  • Publication number: 20210113528
    Abstract: The invention relates to medical uses of an HDAC inhibitor of the below general formula I, wherein R1 to R7 are as described herein, or a salt or solvate thereof in combination with a CD137 agonist for the treatment of cancer.
    Type: Application
    Filed: March 26, 2019
    Publication date: April 22, 2021
    Applicant: 4SC AG
    Inventor: Svetlana HAMM
  • Publication number: 20200261418
    Abstract: The invention relates to methods, compositions and uses for the of treatment of cancer comprising the administration of an HDAC inhibitor as defined herein for the treatment of cancer in combination with at least one immune checkpoint modulator as defined herein.
    Type: Application
    Filed: September 7, 2018
    Publication date: August 20, 2020
    Applicant: 4SC AG
    Inventors: Susanne DANHAUSER-RIEDL, Frank HERMANN, Roland BAUMGARTNER, Svetlana HAMM, Rene BARTZ